GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma
Introduction: Lenvatinib has recently become available as the first-line therapy for advanced hepatocellular carcinoma (HCC), but its molecular mechanism in HCC remains largely unknown. Objectives: The current study aims to identify the molecular mechanisms of lenvatinib in HCC. Methods: Gene expres...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2023-02-01
|
| Serie: | Journal of Advanced Research |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2090123222000741 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|